Israel Active

In the past year, United with Israel (UWI) published over 2,000 articles and 60 videos in English, Spanish, French and Portuguese about Israel’s activities to combat Covid-19. UWI is a Genesis Foundation “Speak Out for Israel” campaign non-profit organization promoting the truth about Israel.

Shambhavi “Sam” Jha’s cleft palate and lip her made it hard to breathe, hear and talk, despite operations in her native India. After her father moved to Israel as manager of an Indian Bank, Sam was given life-changing treatment at Israel’s Meir hospital and is now studying psychology at Tel Aviv University.

Israel’s Sheba Medical Center has signed two agreements with health authorities in Dubai and Abu Dhabi. They cover medical research and medical tourism. Sheba is currently treating 300 UAE diabetics high blood pressure patients both in Israel and with telemedicine.

Mayo Clinic is partnering Israeli-founded Theator (see previously) to bring its artificial intelligence and computer vision technologies to surgical rooms in the US. Theator will support Mayo’s urologists and gynecologists with pre-op preparation and post-op debriefing.

Unilabs, one of Europe’s largest diagnostics companies, is to implement the AI-based cancer diagnostic software from Israel’s Ibex Medical Analytics (see previously). The initial rollout will begin in Sweden and then continue to 16 more European countries.

Israel’s MeMed (see previously) has received Europe’s CE mark for its Covid-19 Severity disease management solution. The 15-min test measures proteins from serum samples and applies machine learning to identify patients likely to suffer a severe form of coronavirus infection.

Israel’s Redhill has completed its Phase 2 / 3 clinical trials of its opaganib treatment on 475 coronavirus patients in Israel, Europe and Brazil. In a few weeks it will declare the results. Opaganib works on the patient rather than the virus, preventing the body from allowing the virus to enter the host cells.

Israel’s Oramed will shortly commence clinical trials of its Oravax vaccine - the world’s first oral Covid-19 vaccine (see previously). Phase 1/2 trials will take place at Tel Aviv’s Sourasky (Ichilov) Medical Center with Phase 3 in countries desperate for a vaccine.

Israel’s MediWound (see previously) successfully completed Phase 3 clinical trials of its NexoBrid treatment on children with severe thermal burns. The study evaluated 145 pediatric patients, from newborn to eighteen years of age, across 36 burn centers worldwide.

Solabia-Algatech Nutrition based at Kibbutz Ketura has launched BioGlena from whole Euglena gracilis algae grown on the Kibbutz. BioGlena contains over 55% β-glucan polysaccharides, touted as nature's immune-modulator, helping to prime and support natural immunity.